Registered entity Shanghai Sigma-Audley New Material Technology Co., Ltd
Reconstituting AOD-9604 AOD-9604 is the outlier in this group because it's not a GLP-1 medication
The convergence of GLP-1 signaling with pathways of aginginsulin sensitivity, mitochondrial function, neuroinflammationsuggests these drugs may influence healthspan, not just body weight. (de Cabo & Mattson, 2019) For women entering their 50s and 60s, this convergence is especially powerful
As part of my 4-month experiment taking Wegovy to lose weight, I made no change in my diet and still ate everything I usually did
Henderson, C
Tirzepatide is FDA-approved as Mounjaro (type 2 diabetes, 2022) and Zepbound (chronic weight management, 2023), and is EMA-approved